A biotech company could sue a competitor under the Lanham Act for distributing a press release that allegedly made false claims about a drug both companies manufactured and sold, a U.S. District Court in Massachusetts has ruled.Read More »
Litigation is moving forward against the makers of Pradaxa. More than 100 suits have been filed and the first cases have been scheduled, despite a recent safety review from the Food and Drug Administration concluding that the anticoagulant medicine does ...Read More »
WASHINGTON – In the second of two cases considering what class action plaintiffs must prove to make it past the certification stage, the justices of the U.S. Supreme Court tackled the issue of whether plaintiffs asserting a fraud-on-the-market claim must ...Read More »
Merck & Co. has agreed to pay at least $39 million into a fund to settle a Missouri class action over the marketing of the anti-inflammatory drug Vioxx, according to a tentative settlement agreement.Read More »
An independent watch dog group has reported a 23.8 percent increase in the number of reports of serious adverse events associated with the use of various medications during the first quarter of 2012 as compared to the same time period ...Read More »
The anti-nausea drug Reglan and its generic counterparts were the drugs most frequently cited in litigation in 2011, according to a consumer watchdog’s latest analysis of Food and Drug Administration statistics.
Tagged with: Accutane adverse events Avandia Bayer Chantix Coumadin drug litigation FDA Food and Drug Administration GlaxoSmithKline Hoffman-LaRoche Institute for Safe Medication Practices Johnson & Johnson Levaquin Pfizer Pradaxa prescription drugs Reglan Wyeth Yasmin YazRead More »
Randeep Mann, the former Russellville, Ark. doctor who was sentenced to life in prison after the February 2009 bombing of Arkansas State Medical Board Chair Trent P. Pierce, was found to have caused the wrongful death of a Yell County ...Read More »